Evidence map›Paper›PMID 26321447›Full record

ReviewRadiologic clinics of North America2015

Liver Ablation: Best Practice.

Shane A Wells, J Louis Hinshaw, Meghan G Lubner, Timothy J Ziemlewicz, Christopher L Brace, Fred T Lee

Registry-linked trialAbstract readReview
In one paragraph

Review in Radiologic clinics of North America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05009550 (Effect of Erector Spina Plain), which is not on this map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05009550 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Effect of Erector Spina Plain (ESP) Block on Patient Outcomes in Patients With Liver Tumor Undergoing Radiofrequency Ablation

TypeinterventionalSponsorTC Erciyes UniversityRan2021 to 2021Enrolled30ConditionsHepatic CarcinomaArmsGroup ESP, Non-blocked Group
3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Deep learning-based reconstruction and superresolution for MR-guided thermal ablation of malignant liver lesions.Cancer imaging : the official publication of the International Cancer Imaging Society · 2025
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shane A WellsDepartment of Radiology, University of Wisconsin, 600 Highland Avenue, CSC, Madison, WI 53792, USA. Electronic address: swells@uwhealh.org.
J Louis HinshawDepartment of Radiology, University of Wisconsin, 600 Highland Avenue, CSC, Madison, WI 53792, USA.
Meghan G LubnerDepartment of Radiology, University of Wisconsin, 600 Highland Avenue, CSC, Madison, WI 53792, USA.
Timothy J ZiemlewiczDepartment of Radiology, University of Wisconsin, 600 Highland Avenue, CSC, Madison, WI 53792, USA.
Christopher L BraceDepartment of Radiology, University of Wisconsin, 600 Highland Avenue, CSC, Madison, WI 53792, USA; Department of Biomedical Engineering, University of Wisconsin, 600 Highland Avenue, CSC, Madison, WI 53792, USA.
Fred T LeeDepartment of Radiology, University of Wisconsin, 600 Highland Avenue, CSC, Madison, WI 53792, USA; Department of Biomedical Engineering, University of Wisconsin, 600 Highland Avenue, CSC, Madison, WI 53792, USA.

Funding

Optimizing microwave ablation techniques for targeted cancer therapyR01CA142737 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI BRACE, CHRISTOPHER L · 2010 to 2013
$1.2M
Periodic Contrast-Enhanced CT With HYPR Reconstruction For Ablation MonitoringR01CA149379 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI BRACE, CHRISTOPHER L · 2010 to 2014
$1.2M
NCI NIH HHS R01 CA142737NCI NIH HHS R01CA142737NCI NIH HHS R01 CA149379NCI NIH HHS R01CA149379
6 · The paper itself

Abstract

Tumor ablation in the liver has evolved to become a well-accepted tool in the management of increasing complex oncologic patients. At present, percutaneous ablation is considered first-line therapy for very early and early hepatocellular carcinoma and second-line therapy for colorectal carcinoma liver metastasis. Because thermal ablation is a treatment option for other primary and secondary liver tumors, an understanding of the underlying tumor biology is important when weighing the potential benefits of ablation. This article reviews ablation modalities, indications, patient selection, and imaging surveillance, and emphasizes technique-specific considerations for the performance of percutaneous ablation.

Indexed as

Carcinoma, HepatocellularCatheter AblationColorectal NeoplasmsHumansLiver NeoplasmsPatient SelectionColorectal cancerHCCHepatocellular carcinomaMicrowaveNeuroendocrine cancerRadiofrequencyTumor ablation

Identifiers

PMID26321447
PMCPMC6419975

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.